Hepatitis C Support Group
Hepatitis C is a blood-borne viral disease which can cause liver inflammation, fibrosis, cirrhosis and liver cancer. The hepatitis C virus (HCV) is spread by blood-to-blood contact with an infected person's blood. Many people with HCV infection have no symptoms and are unaware of the need to seek treatment. Hepatitis C infects an estimated 150-200 million people worldwide.
It's all about ownership of drugs and dominating the market.
The trial you talk of, combine drugs from different pharmaceutical companies. Gilead is working on it's own combos so they don't have to share the profits.
It's profits before people.
The sofosbuvir/ledipasvir is not at FDA ..yet!